losartan has been researched along with carbon tetrachloride in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Huang, X; Li, D; Lu, H; Wang, Z; Wei, H; Zhan, Y | 1 |
| Calès, P; Chappard, D; Croquet, V; Douay, O; Gallois, Y; Moal, F; Oberti, F; Roux, J; Veal, N; Vuillemin, E; Wang, J | 1 |
| Jun, L; Qiang, CJ; Wei, YH | 1 |
| Abdallah, HM; El-Batran, SA; El-Demerdash, E; Salam, OM; Shaffie, NM | 1 |
| Choi, BH; Choi, JH; Hong, JT; Jang, MJ; Jeon, JH; Joo, SS; Kim, YB; Oh, KW; Park, D; Shin, S; Suh, KH | 1 |
| Adesanoye, OA; Bamidele, TO; Ekor, M; Kale, OE; Odewabi, AO; Oritogun, KS | 1 |
| Bahde, R; Hölzen, JP; Kebschull, L; Minin, E; Palmes, D; Schmidt, HH; Siaj, R; Spiegel, HU; Stöppeler, S; Zibert, A | 1 |
| Hwang, OK; Jeong, KS; Kim, AY; Lee, EJ; Lee, EM; Park, JK | 1 |
| Bahabadi, M; Goudarzi, F; Hajilooi, M; Hashemnia, M; Hedayatyanfard, K; Karimi, J; Khanjarsim, V; Kheiripour, N; Khodadadi, I; Mohammadalipour, A; Sheikh, N; Solgi, G | 1 |
11 other study(ies) available for losartan and carbon tetrachloride
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4.
Topics: Alanine Transaminase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Cells, Cultured; Enalapril; Fibrosis; Immunohistochemistry; Liver; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System | 2001 |
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
Topics: Alanine Transaminase; Alkaline Phosphatase; Angiotensin Receptor Antagonists; Animals; Bile Ducts; Bilirubin; Carbon Tetrachloride; Diuresis; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Portal; Ligation; Liver; Liver Cirrhosis; Losartan; Rats; Rats, Sprague-Dawley; Splanchnic Circulation | 2002 |
Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.
Topics: Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Liver Cirrhosis; Losartan; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2004 |
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Glutathione; Hydroxyproline; Lipid Peroxidation; Lisinopril; Liver; Liver Cirrhosis; Liver Function Tests; Losartan; Male; Oxidative Stress; Rats; Renin-Angiotensin System | 2008 |
Comparative antihypertensive activities of losartan and HM70186 in rats with hepatic dysfunction.
Topics: Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Liver Diseases; Losartan; Male; Rats; Rats, Wistar; Time Factors | 2009 |
Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Enalapril; Glutathione; Liver; Losartan; Malondialdehyde; Organ Size; Rats; Rats, Wistar | 2011 |
Role of angiotensin-1 receptor blockade in cirrhotic liver resection.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Biomarkers; Carbon Tetrachloride; Cell Proliferation; Gene Expression Regulation; Hepatectomy; Hepatic Stellate Cells; Hepatocytes; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Liver Regeneration; Losartan; Male; Microcirculation; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Time Factors | 2011 |
Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Carbon Tetrachloride; Disease Models, Animal; Dystrophin; Gene Expression; Immunohistochemistry; Losartan; Mice; Muscle, Skeletal; Muscular Diseases; MyoD Protein; Myogenin; PAX7 Transcription Factor; Phosphorylation; Smad2 Protein; Smad3 Protein | 2016 |
Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Carbon Tetrachloride; Drug Therapy, Combination; Liver Cirrhosis; Losartan; Male; Oxidative Stress; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Wistar; Transforming Growth Factor beta1; Weight Gain | 2020 |